Status:

RECRUITING

Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters

Lead Sponsor:

IBSA Farmaceutici Italia Srl

Collaborating Sponsors:

Informapro Srl

Universita degli Studi di Catania

Conditions:

Weight Loss

Eligibility:

MALE

18-60 years

Phase:

NA

Brief Summary

Evaluation of the efficacy of Phaseolus vulgaris L. dry extract on weight modulation.

Detailed Description

Monocentric, prospective, randomized, single-blind clinical trial to evaluate the effects of Phaseolus vulgaris L. dry extract (test) on weight reduction and on metabolic parameters after 12 weeks of ...

Eligibility Criteria

Inclusion

  • Male subjects aged between 18 and 60 years
  • BMI between 25 and 35 kg/m2
  • Habitual consumption of three main meals a day
  • Stable body weight during the 3 months prior to enrollment
  • Commitment to adhere to the diet and avoid the use of other weight loss products during the study
  • Commitment not to change lifestyle significantly for the entire duration of the study.
  • Signing of informed consent

Exclusion

  • Hypergonadotropic hypogonadism and hypogonadotropic hypogonadism
  • Diabetes mellitus
  • Smoking \> 10 cigarettes/day
  • Alcohol \> 2 alcohol units/day (equal to 24 g of ethanol)
  • History of eating disorders during the 12 months prior to enrollment
  • Use of any drug or product to treat obesity (e.g. meal replacements)
  • Presence of acute or chronic gastrointestinal diseases
  • Active use of drugs that could influence the functions: gastrointestinal (e.g. laxatives, etc.), insulin (insulin sensitizers, etc.) and/or testicular (hormones, substances that influece testosterone production
  • Known sensitivity to the ingredients of the preparation
  • Any other clinical condition judged by the investigator to be incompatible with participation in the trial

Key Trial Info

Start Date :

November 8 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06193577

Start Date

November 8 2023

End Date

June 30 2025

Last Update

January 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

A.O.U. Policlinico "G. Rodolico - San Marco"

Catania, Catania, Italy, 95123